Quantel Medical Sells 400th Multispot Laser
Company Milestone Shows Positive Global Response to its Laser Therapeutics
CLERMONT-FERRAND, France, Oct. 8, 2013
CLERMONT-FERRAND, France, Oct. 8, 2013 /PRNewswire/ --Quantel Medical, a
world leader in ophthalmic ultrasound and laser devices, today announced that
it recently sold its 400^th Multispot laser for the treatment of retinal
disease, including, among others, diabetic macular edema (DME), central serous
retinopathy and retinal vein occlusion (RVO). Quantel's two Multispot laser
systems – the SupraScan™ 577 and Vitra Multispot™ – offer a comprehensive
range of treatment patterns in conjunction with precisely controlled laser
emission, providing an improved experience for both patient and physician.
Both Multispot lasers leverage pattern-scanning technology to achieve optimal
treatment results. Short, 10-20ms pulses are placed in a variety of potential
patterns, resulting in reduced heat diffusion to the retina and choroid and,
subsequently, reduced collateral damage to surrounding tissue. Multispot
treatment is characterized by a more comfortable experience for patients,
extremely efficient treatment (full pan-retinal photocoagulation (PRP) is
possible in 2 sessions), and shorter laser sessions, when compared to
traditional laser treatment.
"The sale of our 400^th Multispot laser constitutes a critical milestone for
Quantel," noted Mr. Jean-Marc Gendre, CEO of Quantel Medical. "Quantel's
pattern-scanning laser technologies provide retinal specialists and
comprehensive ophthalmologists the highest-quality technology to achieve
optimum treatment results. As we continue to innovate, we will bring
additional best-in-class technologies to ophthalmologists across the world."
The SupraScan 577 is a 577nm photocoagulation laser that adapts to Haag
Streit-type slit lamps. 577nm wavelength treatment is both efficient and
efficacious, utilizing less power during treatment and achieving excellent
combined absorption by both melanin and oxyhemoglobin, making 577nm an ideal
choice for penetrating cataracts and hazy media. Additionally, the system is
capable of performing MicroPulse™*, a tissue-sparing treatment mode that
segments laser delivery into a sequence of extremely short, microsecond
The Vitra Multispot is a 532nm portable multispot laser that also adapts to
Haag Streit-type slit lamps. The system utilizes electronically controlled
laser emissions based on the "Start and Stop" principle: unlike other lasers,
the system does not use galvo mirrors to control pulse duration, resulting in
a laser beam always perfectly centered in the fiber and laser pulses generated
and controlled by the laser itself. Subsequently, this technology ensures
excellent spot-to-spot laser burn consistency, and that fluence is controlled
and consistent for each spot.
About Quantel Medical
Founded in 1993 and headquartered in Clermont-Ferrand, France, Quantel Medical
is a global ophthalmic medical device company dedicated to developing leading
technologies to improve the treatment of ocular diseases. Quantel Medical has
a strong emphasis in research and development, resulting in many
first-to-market product introductions and a comprehensive product portfolio of
diagnostic ultrasound and surgical lasers for ophthalmologists. These products
are available through direct sales operations in the U.S. and France, and
through independent distributors in over 80 countries.
Quantel Medical is a division of Quantel (QUA:EN), a world-wide leader in the
development of solid-state lasers for scientific and industrial applications.
For more information, please visit www.quantel-medical.com.
* MicroPulse is a trademark of and used under license from IRIDEX Corporation.
SOURCE Quantel Medical
Contact: Levi Hall, Marketing Director, LHall@quantelusa.com, +1-916-704-5384,
or Media Contact, Michael Elofer, Pascale Communications,
Press spacebar to pause and continue. Press esc to stop.